On May 22, 2025 Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, reported that management will present at the following investor conferences (Press release, Enliven Therapeutics, MAY 22, 2025, View Source [SID1234653338]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen’s 6th Annual Oncology Innovation Summit: Insights from ASCO (Free ASCO Whitepaper) & EHA (Free EHA Whitepaper)
Format: Fireside Chat
Date: Tuesday, May 27, 2025
Time: 1:00 p.m. ET

Jefferies Global Healthcare Conference
Format: Fireside Chat
Date: Wednesday, June 4, 2025
Time: 4:20 p.m. ET

Goldman Sachs Annual Global Healthcare Conference
Format: Fireside Chat
Date: Tuesday, June 10, 2025
Time: 4:00 p.m. ET

The fireside chats will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at View Source Each webcast will be archived for a period of 90 days following the conclusion of the live event.